Sotera Health (NASDAQ:SHC) Receives Average Rating of “Moderate Buy” from Brokerages

Sotera Health (NASDAQ:SHC) has been assigned a consensus recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $16.00.

Several research analysts have issued reports on the company. The Goldman Sachs Group started coverage on Sotera Health in a report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target on the stock. Barclays cut their target price on Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a report on Friday, February 28th.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Blue Trust Inc. grew its holdings in Sotera Health by 164.3% during the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after buying an additional 1,140 shares in the last quarter. Quarry LP purchased a new position in Sotera Health during the 4th quarter worth $28,000. True Wealth Design LLC bought a new stake in shares of Sotera Health in the 3rd quarter worth $32,000. GAMMA Investing LLC grew its stake in shares of Sotera Health by 37.5% in the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after acquiring an additional 1,121 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock valued at $82,000 after purchasing an additional 1,640 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

SHC stock opened at $11.93 on Wednesday. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.08. The stock has a market capitalization of $3.38 billion, a PE ratio of 47.72 and a beta of 1.92. The company’s 50-day moving average is $12.90 and its 200-day moving average is $14.08. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.